$17.79
MEDIFAST is a personal services business based in the US. MEDIFAST shares (MED) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $18.46 – an increase of 0.6% over the previous week. MEDIFAST employs 634 staff and has a trailing 12-month revenue of around $770.2 million.
Our top picks for where to buy MEDIFAST stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy MEDIFAST stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MED. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy MEDIFAST stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
MEDIFAST stock price (NYSE: MED)
Use our graph to track the performance of MED stocks over time.MEDIFAST shares at a glance
Latest market close | $18.46 |
---|---|
52-week range | $17.73 - $77.69 |
50-day moving average | $19.22 |
200-day moving average | $32.16 |
Wall St. target price | $17.25 |
PE ratio | 6.8881 |
Dividend yield | N/A |
Earnings per share (TTM) | $2.68 |
Is it a good time to buy MEDIFAST stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
MEDIFAST price performance over time
Historical closes compared with the close of $18.46 from 2024-10-08
1 week (2024-10-02) | 0.60% |
---|---|
1 month (2024-09-10) | -2.28% |
3 months (2024-07-10) | -1.44% |
6 months (2024-04-10) | -42.11% |
1 year (2023-10-10) | -75.26% |
---|---|
2 years (2022-10-07) | -83.86% |
3 years (2021-10-08) | 192.08 |
5 years (2019-10-10) | 89.3702 |
Is MEDIFAST stock undervalued or overvalued?
Valuing MEDIFAST stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MEDIFAST's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MEDIFAST's P/E ratio
MEDIFAST's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, MEDIFAST shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
MEDIFAST's PEG ratio
MEDIFAST's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MEDIFAST's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MEDIFAST's EBITDA
MEDIFAST's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $47.3 million.
The EBITDA is a measure of a MEDIFAST's overall financial performance and is widely used to measure a its profitability.
MEDIFAST financials
Revenue TTM | $770.2 million |
---|---|
Gross profit TTM | $1.1 billion |
Return on assets TTM | 6.99% |
Return on equity TTM | 15.01% |
Profit margin | 3.81% |
Book value | $19.27 |
Market Capitalization | $201.9 million |
TTM: trailing 12 months
MEDIFAST share dividends
Dividend payout ratio: 61.57% of net profits
Recently MEDIFAST has paid out, on average, around 61.57% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), MEDIFAST shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In MEDIFAST's case, that would currently equate to about $N/A per share.
MEDIFAST's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
MEDIFAST's most recent dividend payout was on 6 November 2023. The latest dividend was paid out to all shareholders who bought their shares by 17 September 2023 (the "ex-dividend date").
MEDIFAST share price volatility
Over the last 12 months, MEDIFAST's shares have ranged in value from as little as $17.73 up to $77.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MEDIFAST's is 1.162. This would suggest that MEDIFAST's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
MEDIFAST overview
Medifast, Inc. , through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. .
Frequently asked questions
What percentage of MEDIFAST is owned by insiders or institutions?Currently 2.545% of MEDIFAST shares are held by insiders and 97.87% by institutions. How many people work for MEDIFAST?
Latest data suggests 634 work at MEDIFAST. When does the fiscal year end for MEDIFAST?
MEDIFAST's fiscal year ends in December. Where is MEDIFAST based?
MEDIFAST's address is: 100 International Drive, Baltimore, MD, United States, 21202 What is MEDIFAST's ISIN number?
MEDIFAST's international securities identification number is: US58470H1014 What is MEDIFAST's CUSIP number?
MEDIFAST's Committee on Uniform Securities Identification Procedures number is: 42221F101
More guides on Finder
-
How to buy Samsara stock (Samsara)
Steps to owning and managing IOT, with 24-hour and historical pricing before you buy.
-
How to buy Udemy stock (UDMY)
Steps to owning and managing UDMY, with 24-hour and historical pricing before you buy.
-
How to buy Remitly Global stock (Remitly)
Steps to owning and managing RELY, with 24-hour and historical pricing before you buy.
-
How to buy Genius Group Limited stock (Genius Group Limited)
Steps to owning and managing GNS, with 24-hour and historical pricing before you buy.
-
How to buy GEE Group stock (JOB)
Steps to owning and managing JOB, with 24-hour and historical pricing before you buy.
-
How to buy Service Corporation International stock (SCI)
Steps to owning and managing SCI, with 24-hour and historical pricing before you buy.
-
How to buy NeoGenomics stock (NEO)
Steps to owning and managing NEO, with 24-hour and historical pricing before you buy.
-
How to buy Vivint Smart Home stock (VVNT)
Steps to owning and managing VVNT, with 24-hour and historical pricing before you buy.
-
How to buy DexCom stock (DXCM)
Steps to owning and managing DXCM, with 24-hour and historical pricing before you buy.
-
How to buy Cerner stock (CERN)
Steps to owning and managing CERN, with 24-hour and historical pricing before you buy.
Ask a question